8.10 USD
↗ 0.12 (1.50%)AT CLOSE (11:59 AM EDT)
Kyntra Bio, Inc. Common Stock
KYNBNASDAQ • USD
7.54
↘ 0.56 (6.98%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
7.54
↘ 0.56 (6.98%)
Market: OPEN
Kyntra Bio, Inc. Common Stock (KYNB) trades at $7.54 per share. Technical indicators currently signal "Strong Buy". Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 25, 2026.
Open?$8.00
High?$8.12
Low?$7.75
Prev. Close?$7.98
Volume?45.2K
Avg. Volume?10.2K
VWAP?$7.97
Rel. Volume?4.41x
Bid / Ask
Bid?$6.02 × 100
Ask?$9.30 × 100
Spread?$3.28
Midpoint?$7.66
Valuation & Ratios
Market Cap?32.3M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.18
P/B Ratio?-1.07
EPS?$45.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Themes
Employees
34
Market Cap
32.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?2.53%Low
Short Interest?98.2K
Days to Cover?14.2
Free Float3.9M
Avg Daily Volume6.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.69Strong
Quick Ratio?2.59Strong
Cash Ratio?1.41Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?0.2CHEAP▾
Peers100
S&P97
P/B?-1.07CHEAP▾
S&P97
P/S?7.00FAIR▾
Peers100
S&P17
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?-3.97CHEAP▾
S&P97
Returns & Efficiency
ROE?-607.7%WEAK▾
S&P3
ROA?181.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-38062000
Enterprise Value?$-18331990
Fundamentals ratios updated end of day